181 related articles for article (PubMed ID: 31605777)
1. The influence of patient sex on clinical approaches to malignant glioma.
Matteoni S; Abbruzzese C; Villani V; Malorni W; Pace A; Matarrese P; Paggi MG
Cancer Lett; 2020 Jan; 468():41-47. PubMed ID: 31605777
[TBL] [Abstract][Full Text] [Related]
2. Consensus on the role of human cytomegalovirus in glioblastoma.
Dziurzynski K; Chang SM; Heimberger AB; Kalejta RF; McGregor Dallas SR; Smit M; Soroceanu L; Cobbs CS;
Neuro Oncol; 2012 Mar; 14(3):246-55. PubMed ID: 22319219
[TBL] [Abstract][Full Text] [Related]
3. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
Parvez T
Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
[TBL] [Abstract][Full Text] [Related]
4. Malignant astrocytic gliomas in children.
Marchese MJ; Chang CH
Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
[TBL] [Abstract][Full Text] [Related]
5. The post-surgical era of GBM: How molecular biology has impacted on our clinical management. A review.
Monticelli M; Zeppa P; Zenga F; Altieri R; Mammi M; Bertero L; Castellano I; Cassoni P; Melcarne A; La Rocca G; Sabatino G; Ducati A; Garbossa D
Clin Neurol Neurosurg; 2018 Jul; 170():120-126. PubMed ID: 29777944
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant glioma.
Geoerger B; Vassal G; Opolon P; Dirven CM; Morizet J; Laudani L; Grill J; Giaccone G; Vandertop WP; Gerritsen WR; van Beusechem VW
Cancer Res; 2004 Aug; 64(16):5753-9. PubMed ID: 15313916
[TBL] [Abstract][Full Text] [Related]
7. Cure following gene therapy for recurrent glioblastoma multiforme?
Karabatsou K; Bernstein M
Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
[TBL] [Abstract][Full Text] [Related]
8. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
9. Human Papillomavirus and Human Cytomegalovirus Infection and Association with Prognosis in Patients with Primary Glioblastoma in Pakistan.
Adnan Ali SM; Mirza Y; Ahmad Z; Zahid N; Enam SA
World Neurosurg; 2019 Jan; 121():e931-e939. PubMed ID: 30321676
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal analysis of treatment-induced genomic alterations in gliomas.
Erson-Omay EZ; Henegariu O; Omay SB; Harmancı AS; Youngblood MW; Mishra-Gorur K; Li J; Özduman K; Carrión-Grant G; Clark VE; Çağlar C; Bakırcıoğlu M; Pamir MN; Tabar V; Vortmeyer AO; Bilguvar K; Yasuno K; DeAngelis LM; Baehring JM; Moliterno J; Günel M
Genome Med; 2017 Feb; 9(1):12. PubMed ID: 28153049
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.
Lehrer S
Med Hypotheses; 2012 May; 78(5):657-8. PubMed ID: 22385772
[TBL] [Abstract][Full Text] [Related]
12. Brain cancer. A viral link to glioblastoma?
Miller G
Science; 2009 Jan; 323(5910):30-1. PubMed ID: 19119195
[No Abstract] [Full Text] [Related]
13. Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.
Markert JM; Medlock MD; Rabkin SD; Gillespie GY; Todo T; Hunter WD; Palmer CA; Feigenbaum F; Tornatore C; Tufaro F; Martuza RL
Gene Ther; 2000 May; 7(10):867-74. PubMed ID: 10845725
[TBL] [Abstract][Full Text] [Related]
14. Impact of age and gender on glioblastoma onset, progression, and management.
Colopi A; Fuda S; Santi S; Onorato A; Cesarini V; Salvati M; Balistreri CR; Dolci S; Guida E
Mech Ageing Dev; 2023 Apr; 211():111801. PubMed ID: 36996926
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH
Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318
[TBL] [Abstract][Full Text] [Related]
16. Glioma virus therapies between bench and bedside.
Kaufmann JK; Chiocca EA
Neuro Oncol; 2014 Mar; 16(3):334-51. PubMed ID: 24470549
[TBL] [Abstract][Full Text] [Related]
17. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
18. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
19. No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics.
Lehrer S; Green S; Ramanathan L; Rosenzweig K; Labombardi V
Anticancer Res; 2012 Mar; 32(3):1113-5. PubMed ID: 22399642
[TBL] [Abstract][Full Text] [Related]
20. High incidence of TERT mutation in brain tumor cell lines.
Johanns TM; Fu Y; Kobayashi DK; Mei Y; Dunn IF; Mao DD; Kim AH; Dunn GP
Brain Tumor Pathol; 2016 Jul; 33(3):222-7. PubMed ID: 26960334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
